2m 2m 2m 2m 2m 2m 2m
Lifecore Biomed (LFCR)
NASDAQ
$5.68+$0.22 (+4.13%)
Price as of Jun 03, 2026 4:10 PM EDT- $188.3MMarket Cap
- -20.67%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Lifecore Biomed (LFCR)
$5.68+$0.22 (+4.13%)
LFCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.45 | ||
Change | +$0.60 (+12.37%) | ||
Open | $4.87 | ||
High | $5.46 | ||
Low | $4.78 | ||
Previous Close | $4.85 | ||
Volume | 353,873 | ||
30-Day Average Volume | 198,191 | ||
1-Week Change | 13.54% | ||
1-Month Change | 3.61% | ||
1-Year Change | -20.67% | ||
3-Year Change | -33.13% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.5M | ||
Total Assets | $225.5M | ||
Market Cap | $188.3M | ||
Enterprise Value | $179.4M | ||
Period: QTR TTM FY | |||
Revenue | $14.2M | ||
Net Income | -$15.0M | ||
Free Cash Flow | N/A | ||
EBIT | -$7.7M | ||
EBITDA | -$5.4M | ||
Net Working Capital | N/A | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | 13 | ||
P/B | -7 | ||
P/E | -12 | ||
PEG | 0 | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue